Quick Answer
BIODESIX INC reported Research And Development Expense of $12.00 million for the year ending 2025.
- BIODESIX INC showed an increase of +25.5% in Research And Development Expense from 2024 to 2025.
- This data is from BIODESIX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), BIODESIX INC's Research And Development Expense has grown by 14.6%.
- Historical annual values: Fiscal year 2025: $12.00 million | Fiscal year 2024: $9.56 million | Fiscal year 2023: $9.99 million | Fiscal year 2022: $13.10 million | Fiscal year 2021: $12.79 million | Fiscal year 2020: $10.82 million | Fiscal year 2019: $10.47 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: